{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:07:15Z","timestamp":1790003235175,"version":"4.0.1"},"reference-count":21,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj-2026-100749","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:50:11Z","timestamp":1789987811000},"page":"e100749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Improving transparency of drug regulatory decisions"],"prefix":"10.1136","volume":"394","author":[{"given":"Maximilian","family":"Siebert","sequence":"first","affiliation":[{"name":"Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Tibau","sequence":"additional","affiliation":[{"name":"Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026092107451068000_394.sep21_2.e100749.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5221"},{"key":"2026092107451068000_394.sep21_2.e100749.2","doi-asserted-by":"publisher","DOI":"10.1177\/17407745261437363"},{"key":"2026092107451068000_394.sep21_2.e100749.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4129"},{"key":"2026092107451068000_394.sep21_2.e100749.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073711"},{"key":"2026092107451068000_394.sep21_2.e100749.5","unstructured":"European Parliament. Deal on comprehensive reform of EU pharmaceutical legislation. 2025. https:\/\/www.europarl.europa.eu\/news\/en\/press-room\/20251209IPR32110\/deal-on-comprehensive-reform-of-eu-pharmaceutical-legislation"},{"key":"2026092107451068000_394.sep21_2.e100749.6","unstructured":"Council of the European Union. Regulation laying down union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency \u2014 analysis of the final compromise text with a view to agreement. 2026. https:\/\/data.consilium.europa.eu\/doc\/document\/ST-6366-2026-INIT\/en\/pdf"},{"key":"2026092107451068000_394.sep21_2.e100749.7","unstructured":"European Commission. Joint clinical assessment for medicinal products. 2025. https:\/\/health.ec.europa.eu\/document\/download\/ced91156-ffe1-472d-85eb-aa6a91dd707e_en?filename=hta_htar_factsheet-jca_en.pdf"},{"key":"2026092107451068000_394.sep21_2.e100749.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03948-5"},{"key":"2026092107451068000_394.sep21_2.e100749.9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9498"},{"key":"2026092107451068000_394.sep21_2.e100749.10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.6479"},{"key":"2026092107451068000_394.sep21_2.e100749.11","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2021.01927"},{"key":"2026092107451068000_394.sep21_2.e100749.12","unstructured":"European Medicines Agency. Refusal of the marketing authorisation for Aduhelm (aducanumab). 2022. https:\/\/www.ema.europa.eu\/en\/documents\/medicine-qa\/questions-and-answers-refusal-marketing-authorisation-aduhelm-aducanumab_en.pdf"},{"key":"2026092107451068000_394.sep21_2.e100749.13","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.1718"},{"key":"2026092107451068000_394.sep21_2.e100749.14","unstructured":"Lawrence L. As controversial decisions mount, FDA shuns public advisory meetings. STAT. 9 Mar 2026. https:\/\/www.statnews.com\/2026\/03\/09\/fda-cuts-back-advisory-meetings-controversial-decisions-grow\/"},{"key":"2026092107451068000_394.sep21_2.e100749.15","unstructured":"UK Government. Commission on Human Medicines. Membership and summary minutes. 2026. doi:https:\/\/www.gov.uk\/government\/organisations\/commission-on-human-medicines\/about\/membership"},{"key":"2026092107451068000_394.sep21_2.e100749.16","unstructured":"UK Parliament. Medicines and Healthcare products Regulatory Agency: written question 190785, answered 29. June 2023. https:\/\/questions-statements.parliament.uk\/written-questions\/detail\/2023-06-22\/190785\/"},{"key":"2026092107451068000_394.sep21_2.e100749.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2018-111018"},{"key":"2026092107451068000_394.sep21_2.e100749.18","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). International recognition procedure: guidance. 2024. doi:https:\/\/www.gov.uk\/government\/publications\/international-recognition-procedure"},{"key":"2026092107451068000_394.sep21_2.e100749.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2026.101644"},{"key":"2026092107451068000_394.sep21_2.e100749.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2026-137466"},{"key":"2026092107451068000_394.sep21_2.e100749.21","doi-asserted-by":"publisher","DOI":"10.1002\/hast.1525"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100749","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:45:20Z","timestamp":1790001920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":21,"alternative-id":["10.1136\/bmj-2026-100749"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100749","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}